IRadimed Corporation (NASDAQ:IRMD) Q2 2025 Earnings Call Transcript
Operator: Welcome to the IRADIMED CORPORATION Second Quarter of 2025 Financial Results Conference Call.
Iradimed Corp (IRMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 872,003 | $52,137,000 | 15.51% | |
| 2. | Renaissance Technologies Jim Simons | 491,812 | $29,405,439 | -2% | 0.04% |
| 3. | Ranger Investment Management Conrad Doenges (Cio) | 214,840 | $12,845,284 | +8% | 0.9% |
| 4. | Millennium Management Israel Englander | 111,628 | $6,674,238 | +60% | 0% |
| 5. | Roubaix Capital Christopher Hillary | 71,497 | $4,274,806 | +49% | 2.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.85 | 1,000 | $13,850.00 | 21,000 | 2018-03-16 | Filing | |
| $8.65 | 5,000 | $43,250.00 | 20,000 | 2017-02-09 | Filing | |
| $8.55 | 5,000 | $42,750.00 | 15,000 | 2017-02-08 | Filing | |
| $11.24 | 5,000 | $56,190.00 | 10,000 | 2016-11-29 | Filing | |
| $10.46 | 5,000 | $52,280.00 | 5,000 | 2016-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.27 | 200 | $14,454.00 | 2,342,500 | 2025-10-06 | Filing | |
| $71.70 | 4,800 | $344,160.00 | 2,342,700 | 2025-10-06 | Filing | |
| $71.03 | 429 | $30,471.87 | 2,347,500 | 2025-10-01 | Filing | |
| $70.41 | 3,448 | $242,773.68 | 2,347,929 | 2025-10-01 | Filing | |
| $69.20 | 1,123 | $77,711.60 | 2,351,377 | 2025-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,144 | $721,847 | 0% | |
| 2. | 402 | $28,606 | 0.02% | |
| 3. | 157 | $11,173 | 0.01% | |
| 4. | 33 | $2,348 | 0% |
News See All
IRadimed Corporation (NASDAQ:IRMD) Q1 2025 Earnings Call Transcript
Operator: Welcome to the IRADIMED Corporation First Quarter of 2025 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
IRadimed Corporation (NASDAQ:IRMD) Q4 2024 Earnings Call Transcript
Operator: Welcome to the IRADIMED CORPORATION Fourth Quarter of 2024 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
IRadimed Corporation (NASDAQ:IRMD) Q3 2024 Earnings Call Transcript
Operator: Welcome to the IRadimed Corporation Third Quarter of 2024 Financial Results Conference Call.
IRadimed Corporation (NASDAQ:IRMD) Q2 2024 Earnings Call Transcript
Operator: Welcome to the IRadimed Corporation Second Quarter of 2024 Financial Results Conference Call.
IRadimed Corporation (NASDAQ:IRMD) Q1 2024 Earnings Call Transcript
Operator: Welcome to IRADIMED CORPORATION First Quarter of 2024 Financial Results Conference Call.
Should You Invest in IRadimed Corporation (IRMD)?
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript
IRadimed Corporation beats earnings expectations. Reported EPS is $0.39, expectations were $0.37.
IRadimed Corporation (NASDAQ:IRMD) Q3 2023 Earnings Call Transcript
Operator: Welcome to the IRadimed Corporation Third Quarter of 2023 Financial Results Conference Call.
IRadimed Corporation (NASDAQ:IRMD) Q1 2023 Earnings Call Transcript
Operator: Welcome to IRadimed Corporation First Quarter of the 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.